Publications by authors named "Andrew P Grieve"

Claim this Profile
P
Pre-Posterior Distributions in Drug Development and Their Properties.
Andrew P Grieve

Pharm Stat· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Probability of success and group sequential designs.
Andrew P Grieve

Pharm Stat· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
On implementing Jeffreys' substitution likelihood for Bayesian inference concerning the medians of unknown distributions.
Andrew P Grieve

Pharm Stat· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimising the trade-off between type I and II error rates in the Bayesian context.
Rosalind J Walley, Andrew P Grieve

Pharm Stat· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How to design a dose-finding study using the continual reassessment method.
Graham M Wheeler, Adrian P Mander, Alun Bedding, Kristian Brock, Victoria Cornelius, Andrew P Grieve

BMC Med Res Methodol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Statistical issues in first-in-human studies on BIA 10-2474: Neglected comparison of protocol against practice.
Sheila M Bird, Rosemary A Bailey, Andrew P Grieve, Stephen Senn

Pharm Stat· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response-adaptive clinical trials: case studies in the medical literature.
Andrew P Grieve

Pharm Stat· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Idle thoughts of a 'well-calibrated' Bayesian in clinical drug development.
Andrew P Grieve

Pharm Stat· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simulation-based sample-sizing and power calculations in logistic regression with partial prior information.
Andrew P Grieve, Shah-Jalal Sarker

Pharm Stat· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The predictive distribution of the residual variability in the linear-fixed effects model for clinical cross-over trials.
Anja Bertsche, Gerhard Nehmiz, Jan Beyersmann, Andrew P Grieve

Biom J· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How to test hypotheses if you must.
Andrew P Grieve

Pharm Stat· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Limitations of within-person study designs. In reply.
Jennifer M Nicholas, Andrew P Grieve, Martin C Gulliford

J Clin Epidemiol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Within-person study designs had lower precision and greater susceptibility to bias because of trends in exposure than cohort and nested case-control designs.
Jennifer M Nicholas, Andrew P Grieve, Martin C Gulliford

J Clin Epidemiol· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discussion of Trippa, Rosner, and Müller--Bayesian enrichment strategies for randomized discontinuation trials.
Andrew P Grieve

Biometrics· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk and cumulative risk of stroke recurrence: a systematic review and meta-analysis.
Keerthi M Mohan, Charles D A Wolfe, Anthony G Rudd, Peter U Heuschmann, Peter L Kolominsky-Rabas, Andrew P Grieve

Stroke· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cluster randomised trial in the General Practice Research Database: 1. Electronic decision support to reduce antibiotic prescribing in primary care (eCRT study).
Martin C Gulliford, Tjeerd van Staa, Lisa McDermott, Alex Dregan, Gerard McCann, Andrew P Grieve

Trials· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cluster randomized controlled trial of a patient and general practitioner intervention to improve the management of multiple risk factors after stroke: stop stroke.
Charles David Alexander Wolfe, Judith Redfern, Anthony George Rudd, Andrew Peter Grieve, Peter Ulrich Heuschmann

Stroke· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
25 years of Bayesian methods in the pharmaceutical industry: a personal, statistical bummel.
Andrew P Grieve

Pharm Stat· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adaptive designs in clinical drug development: opportunities, challenges, and scope reflections following PhRMA's November 2006 workshop.
Michael Krams, Carl-Fredrik Burman, Vladimir Dragalin, Brenda Gaydos, Andrew P Grieve

J Biopharm Stat· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Flexible design and efficient implementation of adaptive dose-finding studies.
Christopher J Weir, David J Spiegelhalter, Andrew P Grieve

J Biopharm Stat· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of a Bayesian adaptive design in a proof of concept study.
Michael K Smith, Ieuan Jones, Mark F Morris, Andrew P Grieve, Keith Tan

Pharm Stat· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ASTIN: a Bayesian adaptive dose-response trial in acute stroke.
Andrew P Grieve, Michael Krams

Clin Trials· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute Stroke Therapy by Inhibition of Neutrophils (ASTIN): an adaptive dose-response study of UK-279,276 in acute ischemic stroke.
Michael Krams, Kennedy R Lees, Werner Hacke, Andrew P Grieve, Jean-Marc Orgogozo

Stroke· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis